M Lapeyre-Mestre
Overview
Explore the profile of M Lapeyre-Mestre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Errahmani M, Thariat J, Ferrieres J, Panh L, Locquet M, Lapeyre-Mestre M, et al.
Int J Cardiol Heart Vasc
. 2022 Jan;
38:100936.
PMID: 35005214
Background: Among cardiac complications of breast cancer radiotherapy (BC RT), there are very limited data on arrhythmia and conduction disorders, in particular severe cases requiring permanent pacemaker implantation (PPMI). Therefore,...
2.
Conte C, Lapeyre-Mestre M, Hanaire H, Ritz P
Obes Surg
. 2020 Sep;
30(12):4810-4820.
PMID: 32869127
Purpose: The long-term impact of bariatric surgery on the remission of type 2 diabetes (T2DM) remains to be clarified through large nationally representative cohorts. The objectives were to determine the...
3.
Pugnet G, Mounie M, Lapeyre-Mestre M, Moulis G, Sailler L
Rev Med Interne
. 2019 Dec;
41(7):446-450.
PMID: 31883837
Purpose: To evaluate the rate of seasonal influenza vaccination coverage (IVC) in incident giant cell arteritis (GCA) patients compared with controls. Methods: The vaccination rate was estimated from vaccine dispensation....
4.
Walburg V, Rueter M, Lamy S, Compaci G, Lapeyre-Mestre M, Laurent G, et al.
Psychol Health Med
. 2019 Feb;
24(7):781-787.
PMID: 30714815
The aim of this study was to measure the prevalence of FCR among a sample of French lymphoma survivors and to determine factors associated with clinical levels of FCR. The...
5.
Caudrelier L, Moulis G, Lapeyre-Mestre M, Sailler L, Pugnet G
Eur J Intern Med
. 2018 Nov;
60:e16-e17.
PMID: 30448032
No abstract available.
6.
Piel-Julian M, Mahevas M, Germain J, Languille L, Comont T, Lapeyre-Mestre M, et al.
J Thromb Haemost
. 2018 Jul;
16(9):1830-1842.
PMID: 29978544
Summary: Background The aim of this cross-sectional study was to assess risk factors for bleeding in immune thrombocytopenia (ITP) adults, including the determination of platelet count thresholds. Methods We selected...
7.
Moulis G, Lapeyre-Mestre M
Rev Med Interne
. 2018 Mar;
39(10):805-812.
PMID: 29514739
Propensity scores have been proposed in the early 1980s, and are increasingly used in epidemiology since the 2000s. They are is used to minimize the selection bias in observational studies,...
8.
Moulis G, Lapeyre-Mestre M, Adoue D, Sailler L
Rev Med Interne
. 2017 Jan;
38(7):444-449.
PMID: 28131440
During the last decade, the development of large clinical and population-based cohorts led to new findings in the epidemiology and the pharmacoepidemiology of immune thrombocytopenia (ITP). The incidence is estimated...
9.
Moulis G, Lapeyre-Mestre M, Palmaro A, Sailler L
J Thromb Haemost
. 2017 Jan;
15(4):785-791.
PMID: 28078756
Summary: Introduction Risk factors for infection and protective effect of vaccines in immune thrombocytopenia (ITP) patients in the era of rituximab therapy are unknown. Objectives To assess the risk factors...
10.
Moulis G, Sailler L, Lapeyre-Mestre M
J Thromb Haemost
. 2015 Apr;
13(8):1521-2.
PMID: 25903487
No abstract available.